Showing 1,461 - 1,480 results of 131,965 for search '(( a e decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (nn decrease)) ))', query time: 1.83s Refine Results
  1. 1461
  2. 1462
  3. 1463

    HRMECs treated with SUZ12 siRNA demonstrate increased miR-200b expression, decreased VEGF expression and decreased endothelial branching. by Michael Anthony Ruiz (726055)

    Published 2015
    “…However, transfection of SUZ12 siRNA significantly reduced endothelial branching compared to HG+control siRNA. [NG+control siRNA = 5mM D-glucose + 100nM control siRNA, HG+control siRNA = 25mM D-glucose + 100nM control siRNA, HG+EZH2 siRNA = 25mM D-glucose + 100nM EZH2 siRNA, HG+SUZ12 siRNA = 25mM + 100nM SUZ12 siRNA; identical letters represent groups that are not significantly different; p < 0.05; n = 6; data expressed as mean ± SEM, normalized to U6 or β-actin and expressed as a fold change of NG+control siRNA].…”
  4. 1464
  5. 1465
  6. 1466
  7. 1467
  8. 1468
  9. 1469
  10. 1470
  11. 1471
  12. 1472
  13. 1473
  14. 1474
  15. 1475

    Heparin (GAG-hed) inhibits LCR activity of Human Papillomavirus type 18 by decreasing AP1 binding-5 by Rita Villanueva (65963)

    Published 2011
    “…In panel E and F, AP1 and SP1 binding respectively, was tested with the same nuclear protein extract obtained from HeLa cells treated with 5 mg/ml of GAG-hed and harvested 48 h post-treatment. …”
  16. 1476
  17. 1477
  18. 1478
  19. 1479

    WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

    Published 2024
    “…</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”
  20. 1480

    Decreased production of antiviral factors in patients infected with SARS-CoV-2 due to reduced TLR7 expression by Julia Cataldo Lima (22811497)

    Published 2025
    “…<p>The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic presents a major global health challenge. …”